We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A report by the Committee on the Medical Effects of Air Pollutants (COMEAP) on the effects of particulate air pollution on mortality in the UK.
Safety leaflet on opioid medicines to help patients and their families reduce the risks of harm.
The review of the safety of isotretinoin has concluded.
Information and guidance on Social Outcomes Partnerships (also known as Social Impact Bonds) and the Life Chances Fund.
How to use an N-of-1 study to evaluate your digital health product.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
How to use a quasi-experimental study to evaluate your digital health product.
Helping public health practitioners conducting evaluations – using economic evaluation to identify the value gained from an intervention.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).